Book Chapters
Bloch M; Guaraldi G, 2017, 'Bone Biomarkers in HIV', in Biomarkers in Bone Disease, Springer Nature, pp. 755 - 781, http://dx.doi.org/10.1007/978-94-007-7693-7_34
Bloch M; Guaraldi G, 2016, 'Bone Biomarkers in HIV', in , pp. 1 - 27, http://dx.doi.org/10.1007/978-94-007-7745-3_34-1
Journal articles
Behrouzfar K; Han WM; Perera R; Li J; Scull KE; Howlett K; Bloch M; Baker DA; Eu B; Bowden-Reid E; Smith DE; Hoy JF; Woolley I; Finlayson R; Templeton DJ; Matthews GV; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Petoumenos K; Dharan NJ; Yeh P; Dawson SJ; Dawson MA; Sinclair B; Templeton DJ; O’Bryan J; Woolley I; Price S; Hoy JF; Acklom K; Lau H; Eu B; Vincent T; Han WM, 2026, 'Mosaic chromosomal alterations are suppressed in older adults with HIV', Communications Biology, 9, http://dx.doi.org/10.1038/s42003-026-10532-1
Eassey D; Ong JJ; Koh K; Nolan D; Baker D; O’Reilly M; Eu B; Lau J; Bisshop F; Kent J; Doblado-Maldonado A; Cowley D; Bloch M, 2026, 'ARMED: an Australian cohort retrospective observational study to understand motivations for switching and clinical outcomes of individuals switching to dolutegravir/lamivudine', Sexual Health, 23, http://dx.doi.org/10.1071/SH26036
Orkin C; Ruane PJ; Hedgcock M; Gaultier C; Losso MH; Trottier B; Lutz T; O'Reilly M; Bloch M; Slim J; Ramgopal M; Sokhela S; Mounzer K; Tsai HC; Santana Bagur JL; Zhang X; Aizen K; Price K; Margot N; Montezuma-Rusca JM; Sklar P; Rhee M; Cahn P; Singh Y; Yokomaku Y; Shirasaka T; Kim SW; Choi JY; Lu PL; Cheng SH; Tsai HC; Adon Moreta C; Santiago L; Cua E; Ghosn J; Pourcher V; Rubenstein E; Boesecke C; Grunwald S; Hoffmann C; Jonsson-Oldenbüttel C; Lutz T; Antinori A; Castagna A; Di Perri G; Cossu MV; Mussini C; Bernardino de la Serna JI; Estrada V; Lopez Cortes LF; Mallolas Masferrer J; Moreno Guillén S; Clarke A; Nelson M; Post F; Taylor S; Wong A; Lebouche B; Brunetta J; Trottier B; Angel J; Mounzer K; Ogbuagu O; Slim J; Stang A; Stephens JL; Burack J; Benson P; Berhe M; Brinson C; Creticos CM; DeJesus E; Gardner E; Gathe JC; Gaultier C; Gay C; Gorgos L; Hsu RK; Jayaweera D; Little S; McDonald C; Meissner E; Mills A; Oguchi G; Osiyemi O; Prelutsky DJ; Ramgopal MN; Ruane PJ; Sanchez W; Scribner A; Sension M; Shalit P; Sims J; Sinclair GI; Tellez M; Thedinger B, 2026, 'Switch to single-tablet bictegravir–lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial', Lancet, 407, pp. 1249 - 1258, http://dx.doi.org/10.1016/S0140-6736(26)00307-7
Orkin C; Mngqibisa R; Velez JD; Kumar P; Braun DL; Carr A; Bloch M; Walmsley S; Tebas P; Yokomaku Y; Diamond TL; Jackson B; Eves K; Grandhi A; Fuszard M; Klopfer SO; Stamm LM; Fox MC; Kim J, 2026, 'Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial', Lancet, 407, pp. 599 - 610, http://dx.doi.org/10.1016/S0140-6736(25)01945-2
Mngqibisa R; Kassim S; McDonald C; Bloch M; Colin-Benoit E; Bettacchi C; Johnson M; Gatanaga H; Kim E; Nwoke U; Fox MC; Stamm LM; Li M; Greaves W, 2026, 'P-369. Safety and Efficacy of Doravirine/Islatravir (DOR/ISL) 100/0.25 mg Once Daily (QD) after ISL Dose Reduction from 0.75 mg: Week 48 Results from an Open-Label Phase 3 Study', Open Forum Infectious Diseases, 13, pp. ofaf695.587, http://dx.doi.org/10.1093/ofid/ofaf695.587
Donoghoe MW; Sazzad HMS; Han WM; Bloch M; Baker DA; Eu B; Bowden-Reid E; Smith DE; Hoy JF; Woolley IJ; Finlayson R; Templeton DJ; Matthews GV; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Agbosu E; Kelleher AD; Petoumenos K; Phetsouphanh C; Yeh P; Dharan NJ; Donoghoe MW; Han WM; Bloch M; Vincent T; Baker DA; Eu B; Lau H; Smith DE; Acklom K; Hoy JF; Price S; Woolley I; O’Bryan J; Finlayson R; Templeton DJ; Sinclair B; Matthews G; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Kelleher AD; Petoumenos K; Yeh P; Dharan NJ, 2026, 'Gut health is associated with clonal haematopoiesis in older adults with and without HIV: the ARCHIVE longitudinal cohort study', Gut, pp. gutjnl-2025-337620, http://dx.doi.org/10.1136/gutjnl-2025-337620
Poynten IM; Turner RC; Varma R; Costello J; Hillman RJ; McCloskey J; Ong JJ; Sever Z; Givan J; Armstrong B; Clifton B; Koh K; Elliott S; Bloch M; Hoy J; Grulich AE; Roberts JM, 2025, 'Australian guidelines for anal cancer screening using anal human papillomavirus testing with cytology triage in people living with HIV', HIV Medicine, 26, pp. 1930 - 1938, http://dx.doi.org/10.1111/hiv.70133
Wong IKJ; Dyer CEF; Grulich AE; Jin F; Law C; Polizzotto MN; Bloch M; Varma R; Kelly ML; Roberts JM; Hillman RJ; Poynten IM, 2025, 'Anal Cancer Screening in People Living With HIV: A Pilot Study of Primary HPV Screening With Triage Use of p16/Ki67 Dual Stain', Journal of Acquired Immune Deficiency Syndromes 1999, 100, pp. 224 - 231, http://dx.doi.org/10.1097/QAI.0000000000003731
Mounzer K; Slim J; Ramgopal M; Hedgcock M; Bloch M; Santana J; Aizen K; Zhang X; Sklar P; Montezuma-Rusca JM; Segal-Maurer S, 2025, 'Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf615
Nolan T; Bhusal C; Beran J; Bloch M; Cetin BS; Dinleyici EC; Dražan D; Kokko S; Koski S; Laajalahti O; Langley JM; Rämet M; Richmond PC; Silas P; Tapiero B; Tiong F; Tipton M; Ukkonen B; Ulukol B; Lattanzi M; Trapani M; Willemsen A; Toneatto D, 2025, 'Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial', Lancet Infectious Diseases, 25, pp. 560 - 573, http://dx.doi.org/10.1016/S1473-3099(24)00667-4
Mounzer K; Slim J; Ramgopal M; Hedgcock M; Bloch M; Santana J; Mendes I; Guo Y; Arora P; Montezuma-Rusca JM; Sklar P; Baeten JM; Segal-Maurer S, 2025, 'Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex HIV Treatment Regimen: A Randomized, Open-Label, Multicenter Phase 2 Study (ARTISTRY-1)', Clinical Infectious Diseases, 80, pp. 881 - 888, http://dx.doi.org/10.1093/cid/ciae522
Nolan T; Bhusal C; Hoberman A; Llapur CJ; Voloshyna O; Fink E; Gentile A; Wallace G; Richmond PC; Domachowske JB; Mzolo T; Lattanzi M; Toneatto D; Akinsola A; Ampajwala M; Arya M; Bartlett A; Batra D; Bloch MT; Bordon J; Byars W; Carr JPJ; Ceballos A; De Looze F; Deluca M; Domachowske J; Farjo R; Gilsoul J; Gunner EA; Gupta AK; Hong M; Kasarjian J; Mann D; Marc GP; Matherne PG; Mitchell G; Obed MN; Oä§mahony J; Richmond P; Riera FO; Rok W; Saravolatz L; Silas P; Soto AE; Sullivan K; Surber J; Teijeiro RA; Tiong F; Wadia U; Yut C, 2025, 'Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study', Clinical Infectious Diseases, 80, pp. 752 - 760, http://dx.doi.org/10.1093/cid/ciae622
Han WM; Sazzad HMS; Bloch M; Baker DA; Roth N; Bowden-Reid E; Smith DE; Hoy JF; Woolley I; Finlayson R; Templeton DJ; Matthews GV; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Petoumenos K; Yeh P; Dharan NJ; Winter D; Baker D; Lau H; Acklom K; Price S; O'Bryan J; Sinclair B; Finlayson R, 2024, 'Age-related clonal hematopoiesis and HIV infection are associated with geriatric outcomes: The ARCHIVE study', Cell Reports Medicine, 5, pp. 101835, http://dx.doi.org/10.1016/j.xcrm.2024.101835
Jiamsakul A; Rupasinghe D; Woolley I; Choi JY; Templeton DJ; Widhani A; Petoumenos K; Tanuma J; Ly PS; Khol V; Zhang FJ; Zhao HX; Han N; Lee MP; Li PCK; Kwong TS; Li TH; Kumarasamy N; Ezhilarasi C; Pujari S; Joshi K; Gaikwad S; Chitalikar A; Sangle S; Mave V; Marbaniang I; Nimkar S; Merati TP; Wirawan DN; Yuliana F; Yunihastuti E; Maria S; Karjadi TH; Oka S; Nishijima T; Na S; Kim JM; Gani YM; Rudi NB; Azwa I; Kamarulzaman A; Syed Omar SF; Ponnam-Palavanar S; Ditangco R; Pasayan MK; Mationg ML; Chan YJ; Ku WW; Wu PC; Ke E; Ng OT; Lim PL; Lee LS; Yap T; Avihingsanon A; Gatechompol S; Phanuphak P; Phadungphon C; Kiertiburanakul S; Phuphuakrat A; Chumla L; Sanmeema N; Chaiwarith R; Sirisanthana T; Praparattanapan J; Nuket K; Khusuwan S; Kantipong P; Kambua P; Nguyen KV; Bui HV; Nguyen DTH; Do CD; Ngo AV; Nguyen LT; Sohn AH; Ross JL; Petersen B; Law MG; Ellis D; Bloch M; Winter D; Soma S; Murphy L; Marci S; Coleman I; Burton L; Baker D; Byrne E; Williamson C; Garton L; Doyle T; Jackson E; Ryder N; Sweeney G; Moran B; Carr A; Hesse K; Hawkes A, 2024, 'HIV Treatment Outcomes After 10 years on ART in the TREAT Asia Observational Database and Australian HIV Observational Database', Journal of Acquired Immune Deficiency Syndromes 1999, 97, pp. 460 - 470, http://dx.doi.org/10.1097/QAI.0000000000003515
Martinello M; Carson JM; Post JJ; Finlayson R; Baker D; Read P; Shaw D; Bloch M; Doyle J; Hellard M; Filep E; Hosseini-Hooshyar S; Dore GJ; Matthews GV, 2024, 'Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae665
Tusch E; Ryom L; Pelchen-Matthews A; Mocroft A; Elbirt D; Oprea C; Günthard HF; Staehelin C; Zangerle R; Suarez I; Vehreschild JJ; Wit F; Menozzi M; d’Arminio Monforte A; Spagnuolo V; Pradier C; Carlander C; Suanzes P; Wasmuth JC; Carr A; Petoumenos K; Borgans F; Bonnet F; De Wit S; El-Sadr W; Neesgaard B; Jaschinski N; Greenberg L; Hosein SR; Gallant J; Vannappagari V; Young L; Sabin C; Lundgren J; Peters L; Reekie J; Calvo G; Dabis F; Kirk O; Law M; Morfeldt L; Reiss P; Weber R; Salbøl Brandt R; Hillebreght M; Zaheri S; Scherrer A; Schöni-Affolter F; Rickenbach M; Tavelli A; Fanti I; Leleux O; Mourali J; Le Marec F; Boerg E; Thulin E; Sundström A; Bartsch G; Thompsen G; Necsoi C; Delforge M; Fontas E; Caissotti C; Dollet K; Mateu S; Torres F; Blance A; Huang R; Puhr R; Grønborg Laut K; Kristensen D; Hatleberg CI; Lind-Thomsen A; Brandt RS; Raben D; Matthews C; Bojesen A; Grevsen AL; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Smith CJ; Phillips AN; Weber R; Morlat P; Friis-Møller N, 2024, 'Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration', Clinical Infectious Diseases, 79, pp. 1242 - 1257, http://dx.doi.org/10.1093/cid/ciae228
Nolan T; Bhusal C; Beran J; Bloch M; Cetin BS; Dinleyici EC; Dražan D; Kokko S; Koski S; Laajalahti O; Langley JM; Rämet M; Richmond PC; Silas P; Tapiero B; Tiong F; Tipton M; Ukkonen B; Ulukol B; Lattanzi M; Trapani M; Willemsen A; Toneatto D; Ackerman R; Adamovska R; Athan E; Ayesu K; Bernard D; Byars W; Carter R; Cetin B; Chakerian M; Dalebout M; De Looze F; Dinleyici EC; Dionne M; Dzongowski P; Farjo R; Finn D; Freeman G; Gottfredson R; Grubb P; Gupta A; Ince T; Jeanfreau R; Jones J; Kellner J; Kiiroja K; Lechevin I; Mehta H; Meisalu S; Morelle D; Osowa A; Paavola P; Patel M; Pavlasek M; Pelayo E; Raulier S; Rok W; Rouhbakhsh R; Sadarangani M; Sanchez Y; Schear M; Scott J; Seppä I; Simon W; Spaziererova M; Staben J; Surber J; Vachon ML; Vale N; Wauters D; Zemanek J, 2024, '4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results from a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae638
Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Templeton DJ; Zablotska-Manos I; Hoy J; Bloch M; Baker D; Brown G; Grulich A; Bavinton B; Pinto AN; Orth D; Roth N; Moore R; Tee BK; Pell C; McNulty A; Doong N; Triffitt K; Koelsch KK; Wilson D; Emery S; Kelleher A; Cooper DA; Grinsztejn B; Zablotska IB, 2024, 'Condom Failure Among HIV-Negative Men in Serodiscordant Relationships in Australia, Brazil, and Thailand', AIDS and Behavior, 28, pp. 3587 - 3595, http://dx.doi.org/10.1007/s10461-024-04431-x
Traeger MW; Guy R; Taunton C; Chow EPF; Asselin J; Carter A; Aung HL; Bloch M; Fairley CK; McNulty A; Cornelisse VJ; Read P; Owen L; Ryder N; Templeton DJ; O'Donnell D; Donovan B; Hellard ME; Stoové MA, 2024, 'Syphilis testing, incidence, and reinfection among gay and bisexual men in Australia over a decade spanning HIV PrEP implementation: an analysis of surveillance data from 2012 to 2022', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101175
Chow L; Presanis J; McIntyre N; Henderson S; Bloch M; Hutton E; Cantillon M, 2024, 'Tricaprilin (CER-0001) for the preventive treatment of migraine: A phase 2 randomised, double-blind, placebo-controlled pilot study', Journal of the Neurological Sciences, 464, http://dx.doi.org/10.1016/j.jns.2024.123147
Harney BL; Sacks-Davis R; Traeger M; van Santen DK; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews G; Donovan B; Guy R; Hellard ME; Doyle JS, 2024, 'Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance data', Sexually Transmitted Infections, 100, pp. 295 - 301, http://dx.doi.org/10.1136/sextrans-2024-056175
Bennett C; Rivers EJ; Woo W; Bloch M; Cheung K; Griffin P; Mohan R; Deshmukh S; Arya M; Cumming O; Neville AM; Pardey TMC; Plested JS; Cloney-Clark S; Zhu M; Kalkeri R; Patel N; Buchanan A; Marcheschi A; Swan J; Smith G; Cho I; Glenn GM; Walker R; Mallory RM, 2024, 'Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial', Journal of Infectious Diseases, 230, pp. e4 - e16, http://dx.doi.org/10.1093/infdis/jiad508
Bennett C; Woo W; Bloch M; Cheung K; Griffin P; Mohan R; Deshmukh S; Arya M; Cumming O; Neville AM; McCallum Pardey TG; Plested JS; Cloney-Clark S; Zhu M; Kalkeri R; Patel N; Marcheschi A; Swan J; Smith G; Cho I; Glenn GM; Walker R; Mallory RM; Anderson A; Ang M; Barnes T; Bassin M; Bessey K; Bowler S; Bull S; Burr L; Burton R; Byrne M; Carroll R; Chee N; Choy A; Clark M; Dalebout M; De Wet P; Deshmukh K; Diez Alvarez S; Douglas D; Engelander J; Evangelista C; Game S; Glass N; Gunner E; Han J; Harrison M; Hing Kiang JD; Hlaing T; Joshi D; Joyce S; Kaluhin K; Kavic M; Kononov J; Lee G; Lee WI; Leelasena I; Leong E; Lim I; Lister G; Loh D; Magdy M; Maggs C; Mammoottil A; McCarthy S; McKay N; Melek M; Michael Barnett A; Moore A; Moore A; Murdoch L; Napier-Flood F; Narsai U; Nguyen P; Odarchenko E; Pardey T; Quan D; Ranagsinghe U; Rasalam R; Rayar S; Ruthnam GJ; Seet P; Smith D; Srilakshmanan K; Taggart A; Tiong F; Toh B; Ujvary E; Wallace S; Wolf R; Wong I; Yoo H; Young R, 2024, 'Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial', Lancet Infectious Diseases, 24, pp. 581 - 593, http://dx.doi.org/10.1016/S1473-3099(24)00077-X
Chammartin F; Mocroft A; Egle A; Zangerle R; Smith C; Mussini C; Wit F; Vehreschild JJ; d’Arminio Monforte A; Castagna A; Bailly L; Bogner J; de Wit S; Matulionyte R; Law M; Svedhem V; Tallada J; Garges HP; Marongiu A; Borges ÁH; Jaschinski N; Neesgaard B; Ryom L; Bucher HC; van der Valk M; Hillebregt M; Petoumenos K; Appoyer H; Delforge M; Wandeler G; Stephan C; Bucht M; Chkhartishvili N; Chokoshvili O; Rodano A; Tavelli A; Fanti I; Borghi V; Pradier C; Fontas E; Dollet K; Caissotti C; Casabona J; Miro JM; Llibre JM; Riera A; Reyes-Urueña J; Lampe F; Lazzarin A; Poli A; Sönnerborg A; Falconer K; Günthard H; Ledergerber B; Kusejko K; Wasmuth JC; Rockstroh J; Fätkenheuer G; Campo R; Lundgren J; McNicholl I; Rooney J; Vannappagari V; Young L; Begovac J; Bruguera A; Dedes N; Kowalska J; Necsoi C; Peters L; Raben D; Anne AV; Williams ED; Greenberg L; Timiryasova A; Bansi-Matharu L; Tusch E; Bannister W; Roen A; Byonanebye D; Fursa O; Pelchen-Matthews A; Grabmeier-Pfistershammer K; Hoy J; Bloch M; Braun D; Calmy A; Schüttfort G; Youle M; Zona S; Antinori A; Bolokadze N; Schwarze-Zander C; Hutchinson J; Duvivier C; Dragovic G; Radoi R; Oprea C, 2024, 'Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus', Clinical Infectious Diseases, 78, pp. 995 - 1004, http://dx.doi.org/10.1093/cid/ciad671
Harney BL; Sacks-Davis R; van Santen DK; Traeger MW; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews GV; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS, 2024, 'Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020', Liver International, 44, pp. 1024 - 1031, http://dx.doi.org/10.1111/liv.15841
Harney BL; Sacks-Davis R; Agius P; van Santen DK; Traeger MW; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews GV; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS; Aung HL; Baillie G; Bastian L; Bateson D; Boyd M; Carter A; Cogle A; Costello J; Dimech W; El-Hayek C; Ellard J; Franklin L; Hocking J; Kim J; Nguyen L; Nguyen T; Nolan D; O’Connor C; Patel P; Pendle S; Polkinghorne V; Reed P; Ryder N; Selvey C; Walker M; Watson N, 2024, 'Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae099
Orkin C; Molina JM; Cahn P; Lombaard J; Supparatpinyo K; Kumar S; Campbell H; Wan H; Teal V; Jin Xu Z; Asante-Appiah E; Sklar P; Teppler H; Lahoulou R; Martins MD; Lopardo GD; Porteiro N; Bloch MT; Baker DA; Roth N; Moore RJ; Finlayson RJ; McMahon J; Rieger A; Zoufaly A; Schmied B; Hartl S; Zangerle R; Smaill F; Walmsley SL; Conway B; Rachlis A; Smith GHR; Perez Cortes C; Afani A; Campos Barker MIE; Chahin Anania CE; Reyes MJW; Gerstoft J; Weis N; Laursen AL; Yazdanpanah Y; Cotte L; Raffi F; Slama L; Morlat P; Girard PM; Katlama C; Rockstroh JK; Arasteh K; Esser S; Stoehr A; Stellbrink HJ; Stoll M; Schuermann D; Faetkenheuer G; Bogner JR; Lutz T; Baumgarten A; Jaeger H; Wiese C; Gori A; Migliorino GM; Coltan G; Constandis F; Erscoiu SM; Prisacariu LJ; Rugina S; Streinu-Cercel A; Pokrovsky VV; Zakharova N; Shuldyakov AA; Ryamova EP; Kulagin VV; Tsybakova OA; Orlova-Morozova E; Nagimova F; Voronin E; Shimonova TE; Kozyrev OA; Orrell C; Botes ME; de Jager M; Segorb JP; Gatell Artigas JM; Mallolas Masferrer J; Guillen SM; Perez Elias MJ; Arribas Lopez JR; Puigmal EN; Podzamczer Palter D; Ortega FP; Garcia JT; de los Santos Gil I; Berenguer J; Nelson MR; Williams IG; Johnson MA, 2024, 'Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials', Lancet HIV, 11, pp. e75 - e85, http://dx.doi.org/10.1016/S2352-3018(23)00258-8
Eu B; Dawe J; Dunn M; Grace J; Lee K; Griffiths S; Bloch M; Baker D; Soo C; Bisshop F; Stoové M, 2024, 'Monitoring and reporting of adverse effects of testosterone prescribing for gender affirmation at general practice clinics - Data from the PUSH! Audit', International Journal of Transgender Health, 25, pp. 770 - 777, http://dx.doi.org/10.1080/26895269.2023.2271903
Essink BJ; Shapiro C; Isidro MGD; Bradley P; Pragalos A; Bloch M; Santiaguel J; Frias MV; Miyakis S; Alves de Mesquita M; Berrè S; Servais C; Waugh N; Hoffmann C; Baba E; Schönborn-Kellenberger O; Wolz OO; Koch SD; Ganyani T; Boutet P; Mann P; Mueller SO; Ramanathan R; Gaudinski MR; Vanhoutte N, 2024, 'Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study', Human Vaccines and Immunotherapeutics, 20, http://dx.doi.org/10.1080/21645515.2024.2408863
Mounzer K; Slim J; Ramgopal M; Hedgcock M; Bloch M; Santana J; Mendes I; Guo Y; Arora P; Montezuma-Rusca JM; Martin H; Sklar P; Barriere G; Baeten J; Segal-Maurer S, 2024, 'Étude de phase 2 évaluant l'association BIC + LEN en prise orale quotidienne chez des personnes ayant un traitement du VIH par plusieurs comprimés', Médecine et Maladies Infectieuses Formation, 3, pp. s136, http://dx.doi.org/10.1016/j.mmifmc.2024.04.376
MacDonald DM; Samorodnitsky S; Wendt CH; Baker JV; Collins G; Kruk M; Lock EF; Paredes R; Poongulali S; Weise DO; Winston A; Wood R; Kunisaki KM; Aagaard B; Jansson PO; Pearson MT; Babiker AG; Arenas-Pinto A; Atako NB; Dennis E; Forcat S; Hudson F; Jackson B; Maas D; Purvis C; Russell C; Emery S; Carey C; Clewett M; Jacoby S; Gordin F; Vjecha M; Sanchez A; Loria GR; Doldan ML; Moricz A; Tillmann K; Müller V; Touloumi G; Gioukari V; Anagnostou O; Herrero P; Lopez P; Avihingsanon A; Rerksirikul P; Loiza E; Mingrone V; Lupo S; Marconi F; Daniel D; Crinejo A; French M; Barba L; Rowling D; Warzywoda E; Bloch M; Agrawal S; Dwyer D; Taylor J; van Petersen L; Mertens L; De Wit S; Kabamba K; Wolff M; Allendes G; Ristola M; Debham O; Jessen H; Jessen A; Wiebecke S; Klinker H; Fätkenheuer G; Lehmann C; Knaevelsrud I; Rittweger M; Stöhr A; Olah K; Schaaf B; Hower M; Harrer T; Harrer E; Skoutelis A; Papastamopoulos V; Metallidis S; Tsachouridou O; Pujari S; Chitalikar A; Kumarasamy N; Beulah F; Shahar E; Kedem E; Turner D; Madero JS; Madrigal C; Filali MKE; Erradey I; Ekong E; Eriobu N; Valencia J; León M, 2023, 'Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-29739-x
Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', Plos One, 18, http://dx.doi.org/10.1371/journal.pone.0289907
Glare P; Chye R; Bloch M; Arya M; Moore A; Montgomery J, 2023, 'Tolerability and Efficacy of a 10:25 Preparation of Δ9-Tetrahydrocannabinol and Cannabidiol for Treatment of Chronic Back or Neck Pain: A Multiple-Dose Escalation Study', Medical Cannabis and Cannabinoids, 6, pp. 66 - 76, http://dx.doi.org/10.1159/000531232
Aung HL; Bloch M; Vincent T; Mao L; Brew BJ; Cysique LA, 2023, 'Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study', Journal of Neurovirology, 29, pp. 141 - 155, http://dx.doi.org/10.1007/s13365-022-01104-0
Eu B; Dawe J; Dunn M; Lee K; Roth N; Griffiths S; Bloch M; Baker D; Soo C; Bisshop F; Stoové M, 2023, 'Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study', HIV Medicine, 24, pp. 236 - 238, http://dx.doi.org/10.1111/hiv.13354
Karver TS; Pascual-Bernaldez M; Berni A; Hnoosh A; Castagna A; Messiaen P; Puerto MJG; Bloch M; Adachi E; Sinclair G; Felizarta F; Angel JB; Sutton K; Sutherland-Phillips D; D'Amico R; Kerrigan D, 2023, 'Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial', AIDS Patient Care and Stds, 37, pp. 53 - 59, http://dx.doi.org/10.1089/apc.2022.0168
Eu B; Dawe J; Dunn M; Lee K; Griffiths S; Bloch M; Baker D; Soo CTM; Bisshop F; Stoové M, 2023, 'Impact of harm reduction practice on the use of nonprescribed performanceand image-enhancing drugs The PUSH! Audit', Australian Journal of General Practice, 52, pp. 197 - 202, http://dx.doi.org/10.31128/AJGP-04-22-6402
Brazier E; Ajeh R; Maruri F; Musick B; Freeman A; Wester CW; Lee MP; Shamu T; Crabtree Ramírez B; d'Almeida M; Wools-Kaloustian K; Kumarasamy N; Althoff KN; Twizere C; Grinsztejn B; Tanser F; Messou E; Byakwaga H; Duda SN; Nash D; Chansilpa C; Dougherty T; Karminia A; Law M; Ross J; Sohn A; Aguirre I; Baker D; Bloch M; Cabot S; Carr A; Couldwell D; Edwards S; Eu B; Farlow H; Finlayson R; Gunathilake M; Hazlewood C; Hoy J; Langton-Lockton J; Le J; Leprince E; Minc A; Moore R; O'Sullivan M; Roth N; Rowling D; Russell D; Ryder N; Saunders C; Silvers J; Smith DJ; Sowden D; Sweeney G; Tan L; Teague R; Templeton D; Thng C; Woolley I; Khol V; Ly PS; Li TH; Po LM; Kinikar A; Mundhe S; Pujari S; Sangle S; Nimkar S; Jassin M; Kurniati N; Merati TP; Muktiarti D; Amalia R; Sukmawati NMDD; Wati KDK; Yunihastuti E; Tanuma J; Choi JY; Azwa RISR; Cheng CK; Gani YM; Mohamed TJ; Moy FS; Nallusamy R; Nor MZM; Rudi N; Shyan WP; Yusoff NKN; Ditangco R; Chan YJ; Wu PC; Wu PF; Avihingsanon A; Chaiwarith R; Chokephaibulkit K; Khusuwan S; Kiertiburanakul S; Kosalaraksa P; Lumbiganon P, 2022, 'Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium', Journal of the International AIDS Society, 25, http://dx.doi.org/10.1002/jia2.26036
Bartlett SR; Verich A; Carson J; Hosseini-Hooshyar S; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Martinez M; Marks P; Dore GJ; Matthews GV; Applegate T; Martinello M, 2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, 5, http://dx.doi.org/10.1002/hsr2.719
Harney BL; Sacks-Davis R; Van Santen DK; Traeger M; Wilkinson AL; Asselin J; El-Hayek C; Fairley CK; Roth N; Bloch M; Matthews G; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS; Bastian L; Bateson D; Bowden S; Boyd M; Callander D; Carter A; Cogle A; Costello J; Dimech W; Dittmer J; Ellard J; Franklin L; Kim J; Mcgill S; Nolan D; Patel P; Pendle S; Polkinghorne V; Nguyen L; Nguyen T; O'connor C; Reed P; Ryder N; Selvey C; Vickers T; Walker M; Watchirs-Smith L; West M, 2022, 'The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019', Clinical Infectious Diseases, 74, pp. 1804 - 1811, http://dx.doi.org/10.1093/cid/ciab720
Boettiger DC; Huque MH; Bloch M; Woolley I; Templeton DJ; Law MG; Fraser N; Hoy J; Petoumenos K, 2022, 'Physical function limitation among gay and bisexual men aged ≥55years with and without HIV: findings from the Australian Positive and Peers Longevity Evaluation Study (APPLES)', Sexual Health, http://dx.doi.org/10.1071/sh22085
Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton D; Zablotska-Manos IB; Hoy J; McNulty A; Pell C; Grulich A; Bavinton B; Grinsztejn B; Cooper DA; Emery S; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Tee BK; Moore R; Roth N; Orth D; Pinto AN, 2021, 'Characteristics of Agreements to have Condomless Anal Intercourse in the Presence of an Undetectable Viral Load Among HIV Serodiscordant Male Couples in Australia, Brazil and Thailand', AIDS and Behavior, 25, pp. 3944 - 3954, http://dx.doi.org/10.1007/s10461-021-03324-7
Drak D; McManus H; Vickers T; Heron JE; Vaccher S; Zablotska I; Guy R; Bavinton B; Jin F; Grulich AE; Bloch M; O'Connor CC; Gracey DM, 2021, 'Renal impairment in a large-scale HIV preexposure prophylaxis implementation cohort', AIDS, 35, pp. 2319 - 2326, http://dx.doi.org/10.1097/QAD.0000000000003035
Greenberg L; Ryom L; Neesgaard B; Wandeler G; Staub T; Gisinger M; Skoll M; Günthard HF; Scherrer A; Mussini C; Smith C; Johnson M; De Wit S; Necsoi C; Pradier C; Wit F; Lehmann C; d'Arminio Monforte A; Miró JM; Castagna A; Spagnuolo V; Sönnerborg A; Law M; Hutchinson J; Chkhartishvili N; Bolokadze N; Wasmuth JC; Stephan C; Vannappagari V; Rogatto F; Llibre JM; Duvivier C; Hoy J; Bloch M; Bucher HC; Calmy A; Anne AV; Pelchen-Matthews A; Lundgren JD; Peters L; Bansi-Matharu L; Mocroft A; Reiss P; Hillebregt M; Petoumenos K; Rose N; Zangerle R; Appoyer H; Delforge M; Bucht M; Chokoshvili O; d'Arminio Monforte A; Rodano A; Tavelli A; Fanti I; Mussini C; Borghi V; Fontas E; Dollet K; Caissotti C; Casabona J; Miro JM; Riera A; Reyes-Urueña J; Lampe F; Lazzarin A; Poli A; Falconer K; Svedhem V; Ledergerber B; Rockstroh J; Vehreschild JJ; Fätkenheuer G; Rooney J; Garges H; Kowalska J; Raben D; Peters L; Volny Anne A; Williams ED, 2021, 'Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living with Human Immunodeficiency Virus', Clinical Infectious Diseases, 73, pp. E2323 - E2333, http://dx.doi.org/10.1093/cid/ciaa1878
Chow CK; Atkins ER; Hillis GS; Nelson MR; Reid CM; Schlaich MP; Hay P; Rogers K; Billot L; Burke M; Chalmers J; Neal B; Patel A; Usherwood T; Webster R; Rodgers A; Hung A; Edison A; Abraham AE; Xu D; Bloch MT; Figtree G; Nolde JM; Black A; Jansen S; Biswas S; Ajani AE; Carnagarin R; Wynne D; Altman M; Thakkar J; Thiagalingam A; Klimis H, 2021, 'Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial', Lancet, 398, pp. 1043 - 1052, http://dx.doi.org/10.1016/S0140-6736(21)01922-X
Gates TM; Kamminga J; Jayewardene A; Vincent T; Quan D; Brew BJ; Bloch M; Cysique LA, 2021, 'Erratum: An examination of reliable change methods for measuring cognitive change with the cogstate computerized battery: Research and clinical implications (Archives of Clinical Neuropsychology (2021) DOI: 10.1093/arclin/acaa076)', Archives of Clinical Neuropsychology, 36, pp. 859, http://dx.doi.org/10.1093/arclin/acaa127
Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R, 2021, 'Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study', Lancet HIV, 8, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(21)00074-6
Gates TM; Kamminga J; Jayewardene A; Vincent T; Quan D; Brew BJ; Bloch M; Cysique LA, 2021, 'An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications', Archives of Clinical Neuropsychology, 36, pp. 597 - 612, http://dx.doi.org/10.1093/arclin/acaa076
Back to profile page
https://orcid.org/0000-0002-1143-5013